openPR Logo
Press release

Chagas Disease Treatment Market - Global Industry Insights, and Forecast till 2025

08-13-2018 05:28 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Chagas Disease Treatment Market - Global Industry Insights,

Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America, due to migration of people from Latin America to others countries. For instance, according a study published in National Center for Biotechnology Information (NCBI), in 2015, 4.2% of Latin American living in European countries were chronically affected with Chagas disease. Benznidazole is the only FDA approved treatment indicated for the treatment of Chagas disease. However, the drug, Nifurtimox manufactured by Bayer AG, is in the World Health Organization's (WHO) list of 'Essential Medicines' and used in the treatment of Chagas disease.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/934

Increasing approval to Chagas disease treatment drugs is expected to drive growth of the global Chagas disease treatment market

Benznidazole is an essential antiparasitic drug used for the treatment of Chagas disease. In April 2018, Argentinian National Administration for Drugs, Food, and Medical Technologies (ANMAT) approved Laboratorio Elea Phoenix SA’s drug benznidazole for pediatric indication used for the treatment of Chagas disease. Currently, Argentina has the highest number of people suffering from Chagas disease. For instance, according to data published by Mundo Sano (Nongovernmental foundation in Argentina), in 2017, around 7,300,000 people were exposed to Chagas disease and about 1,600,000 were infected, in Argentina. Hence, approval of novel drugs is expected to fuel the market growth in the near future. Such approval of Chagas disease treatment drugs is expected to boost growth of Chagas disease treatment market in the near future.

The global Chagas treatment disease market was valued at US$ 5.67 Mn in 2016 and is expected to witness a CAGR of 7.3% over the forecast period (2017–2025).

Rising focus on initiatives by private and government organizations for increasing awareness of Chagas disease

In April 2018, Médecins Sans Frontières/Doctors Without Borders (MSF), an international humanitarian organization, launched a campaign. The campaign is aimed at increasing public awareness about Chagas disease as the disease is still prevalent in Latin American countries, and affects about 6 million people, globally. In 2007, the World Health Organization (WHO) launched a program to increase treatment rate and eliminate Chagas disease. This WHO program was supported by Bayer HealthCare, which manufactures nifurtimox, used in the treatment of Chagas disease. In 2007, Bayer entered into agreement with WHO to support the program by providing 2.5 million tablets free of charge to WHO, for the treatment of an estimated 30,000 patients over a period of five years (from 2007 to 2011). In 2011, WHO and Bayer extended its agreement. According to the agreement, Bayer is expected to provide 5 million tablets, free of charge, from 2012 to 2017. Such initiatives is expected to drive growth of market in the near future

Ask for customization @ https://www.coherentmarketinsights.com/insight/request-customization/934

Diagnostic Methods

Diagnosis of Chagas disease is done by serological methods, parasitological methods, and molecular method. Parasitological methods includes identification of trypomastigotes in blood by microscopy. Polymerase chain reaction (PCR) is a widely used molecular diagnosis method, as it is a good alternative tool for detection and shows high range of efficiency. Serological method is mostly used in the detection of Trypanosoma cruzi antibodies in blood donors, diagnosis of infected people and for epidemic studies. Enzyme-linked Immunosorbent Assay (ELISA), Indirect Immunofluorescence (IIF) are the widely used tests in serological method. The availability of rapid diagnostic test and point of care methods has made diagnosis of the disease more simple and quick. In 2016, InBios International, Inc. received 510K clearance from the U.S. Food and Drug Administration (FDA) for its Chagas Detect Plus Rapid Test Kit (CDP).

Key players operating in the Chagas disease treatment market include Nortec Quimica SA, Bayer AG, Laboratorio Elea Phoenix SA, Maprimed S.A., and Laboratório Farmacêutico de Pernambuco S/A.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chagas Disease Treatment Market - Global Industry Insights, and Forecast till 2025 here

News-ID: 1177533 • Views:

More Releases from Coherent Market Insights

India Sustainable Biopolymers Market Generated Opportunities, Future Scope 2025-2032 |India Glycols Limited, SKYi FKuR Biopolymers Pvt Ltd, Bioplastics India, Biotecnika
India Sustainable Biopolymers Market Generated Opportunities, Future Scope 2025- …
The India Sustainable Biopolymers Market is estimated to be valued at USD 388.9 Mn in 2025 and is expected to reach USD 844.2 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.7% from 2025 to 2032. An Increase in Demand and Opportunities for India Sustainable Biopolymers Market 2025" is the latest intelligence report published by CMI. This report provides a detailed analysis of the India Sustainable Biopolymers industry
Barefoot Shoes Market Projected To Witness Substantial Growth, 2025-2032 |ZAQQ, Chala, Xero Shoes U.K., Tadeevo
Barefoot Shoes Market Projected To Witness Substantial Growth, 2025-2032 |ZAQQ, …
The barefoot shoes market is estimated to be valued at USD 592.3 Mn in 2025 and is expected to reach USD 867.9 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032. An Increase in Demand and Opportunities for Barefoot Shoes Market 2025" is the latest intelligence report published by CMI. This report provides a detailed analysis of the Barefoot Shoes industry through research and
Glass Manufacturing Market is Going to Booming Growth 2025 With Top Key Players Analysis Through 2032|AGC Inc., Fuyao Glass Industry Group Co. Ltd., Guardian Industries, American Insulated Glass
Glass Manufacturing Market is Going to Booming Growth 2025 With Top Key Players …
Global glass manufacturing market is estimated to be valued at USD 130.13 Bn in 2025 and is expected to reach USD 186.93 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032. An Increase in Demand and Opportunities for Glass Manufacturing Market 2025" is the latest intelligence report published by CMI. This report provides a detailed analysis of the Glass Manufacturing industry through research and
Industrial Plastic Market 2025-2032 Emerging Trends in Industry Dynamics, Size Insights, Share, and Future Growth |Exxon Mobil Corporation, Sumitomo Chemical Co., Ltd., BASF SE
Industrial Plastic Market 2025-2032 Emerging Trends in Industry Dynamics, Size I …
The industrial plastic market is estimated to be valued at USD 99.07 Bn in 2025 and is expected to reach USD 152.04 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032. An Increase in Demand and Opportunities for Industrial Plastic Market 2025" is the latest intelligence report published by CMI. This report provides a detailed analysis of the Industrial Plastic industry through research and

All 5 Releases


More Releases for Chagas

Chagas Disease Treatment Market: An In-Depth Analysis
The global Chagas Disease Treatment Market was valued at approximately USD 450 million in 2024 and is projected to reach around USD 700 million by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033 . Chagas Disease Treatment Market Overview Chagas disease, caused by the Trypanosoma cruzi parasite, remains a significant public health challenge, particularly in Latin America. The market's growth is driven by increasing awareness,
Chagas Disease Drug Market Size, Share, Growth Forecast 2023-2032
Chagas disease, caused by the parasite Trypanosoma cruzi, remains a significant public health concern, particularly in Latin America. With an estimated 6 to 7 million people worldwide affected by this neglected tropical disease, the demand for effective treatments has spurred the growth of the Chagas Disease Drug Market. As of 2022, the market size stood at a commendable USD 265.2 million, and projections indicate a robust expansion, with expectations to
Chagas Disease Drug Market Size To Touch USD 520.4 Million By 2032
Chagas Disease Drug Market Size to Occupy More Than USD 520.4 Million by 2032 | CAGR 7.1% from 2023 to 2032 The Chagas Disease Drug Market research report published by Acumen Research and Consulting provides a comprehensive yet detailed analysis of the global market landscape. The report helps our clients understand the market scenario while also providing a detailed historical account of the market over the previous years. The Chagas Disease
2018 – 2024 Chagas Disease Management Market | Global Industry Report
2018 – 2024 Chagas Disease Management Market | Global Industry Report A Recent Market Study On Chagas Disease And Its Current Trends And Future Insights Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by Trypanosoma cruzi. It is transmitted by kissing bugs or triatomine bugs. It can also be transmitted through blood transfusions, in pregnancy, and organ transplantation. In early stage of the Chagas disease, the symptoms include swollen
Chagas Disease Treatment Market Global Industry Insights, and Forecast till 2025
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and